Association between hepatitis B virus infection and colorectal liver metastasis: a meta-analysis

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 Feb;4.
   Web of Science ®Google Scholar
• Hull R, Francies FZ, Oyomno M, et al. Colorectal cancer genetics, incidence and risk factors: in search for targeted therapies. Cancer Manag Res. 2020;9;12:9869–9882.
   PubMed Web of Science ®Google Scholar
• Cao M, Li H, Sun D, et al. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (Lond). 2020;40:205–210.
   PubMed Web of Science ®Google Scholar
• Asbun HJ, Tsao JI, Hughes KS. Resection of hepatic metastases from colorectal carcinoma. The registry data. Cancer Treat Res. 1994;69:33–41.
   PubMedGoogle Scholar
• Sutphin PD, Ganguli S. Interventional Treatment of Hepatic Metastases from Colorectal Cancer. Semin Intervent Radiol. 2020;37:492–498.
   PubMed Web of Science ®Google Scholar
• Lykoudis PM, O’Reilly D, Nastos K, et al. Systematic review of surgical management of synchronous colorectal liver metastases. Br J Surg. 2014;101:605–612.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yu CR. Association between liver targeted antiviral therapy in colorectal cancer and survival benefits: an appraisal. World J Clin Cases. 2020;8(11):2111–2115.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Wong G, Gane E, et al. Hepatitis B virus: advances in prevention, diagnosis, and therapy. Clin Microbiol Rev. 2020;33:e00046–19.
   PubMed Web of Science ®Google Scholar
• Chen S, Mao W, Guo L, et al. Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China. BMJ Glob Health. 2020;5:e002306.
   PubMed Web of Science ®Google Scholar
• Qian HG, Hao CY. Hepatitis B virus infection is an independent factor influencing the occurrence of liver metastasis in colorectal cancer: a retrospective analysis of 1413 cases. Hepatogastroenterology. 2014;61:1908–1914.
   PubMedGoogle Scholar
• Song E, Chen J, Ou Q, et al. Rare occurrence of metastatic colorectal cancers in livers with replicative hepatitis B infection. Am J Surg. 2001;181:529–533.
   PubMed Web of Science ®Google Scholar
• Wang FS, Shao ZG, Zhang JL, et al. Colorectal liver metastases rarely occur in patients with chronic hepatitis virus infection. Hepatogastroenterology. 2012;59:1390–1392.
   PubMedGoogle Scholar
• Qiu HB, Zhang LY, Zeng ZL, et al. HBV infection decreases risk of liver metastasis in patients with colorectal cancer: a cohort study. World J Gastroenterol. 2011;17:804–808.
   PubMed Web of Science ®Google Scholar
• Qian HG, Zhang J, Leng JH, et al. Association of hepatitis B virus infection and cirrhosis with liver metastasis in colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 2010;13:202–204.
   PubMedGoogle Scholar
• Iascone C, Ruperto M, Barillari P. Colorectal carcinoma metastasis in livers infected with hepatitis B or C virus]. Minerva Chir. 2005;60:77–81.
   PubMedGoogle Scholar
• Utsunomiya T, Saitsu H, Saku M, et al. Rare occurrence of colorectal cancer metastasis in livers infected with hepatitis B or C virus. Am J Surg. 1999;177:279–281.
   PubMed Web of Science ®Google Scholar
• Li DG, Castaing M, Ferlito F, et al. Rare hepatic metastases of colorectal cancer in livers with symptomatic HBV and HCV hepatitis. Ann Ital Chir. 2013;84:323–327.
   PubMed Web of Science ®Google Scholar
• Huo T, Cao J, Tian Y, et al. Effect of concomitant positive hepatitis B surface antigen on the risk of liver metastasis: a retrospective clinical study of 4033 consecutive cases of newly diagnosed colorectal cancer. Clin Infect Dis. 2018;66:1948–1952.
   PubMed Web of Science ®Google Scholar
• Zhao L, Song L, Cao J, et al. Active chronic hepatitis B increases the risk of liver metastasis of colorectal cancer: a retrospective clinical study of 7187 consecutive cases of newly diagnosed colorectal cancer. Ann Oncol. 2019;30(Supplement 5):v212.
   Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Lin J, Peng J, et al. Hepatitis B Virus Infection Predicts Better Survival In Patients With Colorectal Liver-only Metastases Undergoing Liver Resection. J Cancer. 2018;9:1560–1567.
   PubMed Web of Science ®Google Scholar
• Lisa JR, Solomon C, Gordon EJ. Secondary Carcinoma in Cirrhosis of the Liver. Am J Pathol. 1942;18:137–140.
   PubMedGoogle Scholar
• Seymour K, Charnley RM. Evidence that metastasis is less common in cirrhotic than normal liver: a systematic review of post-mortem case-control studies. Br J Surg. 1999;86:1237–1242.
   PubMed Web of Science ®Google Scholar
• Fang YJ, Wan DS. Molecular mechanism of liver metastasis from colorectal cancer. Ai Zheng. 2008;27:549–554.
   PubMedGoogle Scholar
• Naito M, Hasegawa G, Ebe Y, et al. Differentiation and function of Kupffer cells. Med Electron Microsc. 2004;37:16–28.
   PubMedGoogle Scholar
• Lara-Pezzi E, Majano PL, Gomez-Gonzalo M, et al. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Hepatology. 1998;28:1013–1021.
   PubMed Web of Science ®Google Scholar
• Wu HL, Kao JH, Chen TC, et al. Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications. J Gastroenterol Hepatol. 2014;29:1629–1636.
   PubMed Web of Science ®Google Scholar
• Bayon LG, Izquierdo MA, Sirovich I, et al. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology. 1996;23:1224–1231.
   PubMed Web of Science ®Google Scholar
• Seki S, Nakashima H, Nakashima M, et al. Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells. Clin Dev Immunol. 2011;2011:868345.
   PubMedGoogle Scholar
• Tordjmann T, Soulie A, Guettier C, et al. Perforin and granzyme B lytic protein expression during chronic viral and autoimmune hepatitis. Liver. 1998;18:391–397.
   PubMedGoogle Scholar
• Shi L, Jackstadt R, Siemens H, et al. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer. Cancer Res. 2014;74:532–542.
   PubMed Web of Science ®Google Scholar
• Wu FL, Jin WB, Li JH, et al. Targets for human encoded microRNAs in HBV genes. Virus Genes. 2011;42:157–161.
   PubMed Web of Science ®Google Scholar